Your session is about to expire
← Back to Search
Chemotherapy/radiation/surgery for Pancreatic Cancer
Study Summary
This trial will test if a new combination of cancer drugs and radiation therapy is effective and safe for treating pancreatic cancer.
- Resectable Pancreatic Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The imaging tests of your chest, abdomen, and pelvis do not show any signs of cancer that has spread to other parts of the body.Based on the results of imaging tests, your cancer is in a stage where it can be removed with surgery or is almost at that stage.You have a medical or psychological condition that is not well controlled and may become worse with the treatment, making it difficult to follow the study plan.You have a history of diseases that cause inflammation in your body, such as collagen vascular disease or inflammatory bowel disease (Crohn's or ulcerative colitis).Your blood test results must show bilirubin levels below 2 mg/dL and AST/ALT levels below 3 times the upper limit of normal. Stenting to improve bile flow is allowed.You are at least 18 years old.You understand the study and willingly agree to follow its rules by signing a consent form.You have received treatment for your condition before.You have received treatment for pancreatic cancer in the past.You have a serious condition affecting your blood vessels in your arms and legs.You have moderate to severe peripheral neuropathy.You are taking warfarin, a medication used to thin the blood.You are able to perform daily activities with little to no assistance.You have been diagnosed with pancreatic cancer that has been confirmed through a biopsy within the last three months.You have enough white blood cells, platelets, and hemoglobin in your blood.
- Group 1: Chemotherapy/radiation/surgery
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this study actively looking for more participants?
"Unfortunately, this clinical trial is not accepting patients at the moment. Although, it's worth mentioning that the study was initially posted on February 17th, 2015 and was most recently edited on May 6th, 2022. For other trials, 597 are currently recruiting for pancreas and 1164 for this specific treatment."
To what number of people will this clinical trial have access?
"This study is no longer recruiting new patients, as evident by the clinical trial's last update on May 6th, 2022. If you are looking for other similar studies, 597 studies involving the pancreas are actively recruiting and 1164 studies for this type of treatment are admitting patients."
Are there any other investigatory papers that explore this form of care?
"There are 1164 ongoing clinical trials related to this treatment, with 329 of them being in the third phase. The majority of these studies are based in Shanghai, but there are 59212 locations running these trials in total."
What are the conditions that this medication is usually effective against?
"This treatment is commonly used to manage neoplasm metastasis, but it can also help patients with other conditions such as locally advanced non-small cell lung cancer, metastatic bladder cancer, and urinary bladder."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger